Bioventus (BVS) Non-Current Deferred Tax Liability (2020 - 2026)

Bioventus (BVS) has 7 years of Non-Current Deferred Tax Liability data on file, last reported at $568000.0 in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deferred Tax Liability fell 6.43% year-over-year to $568000.0; the trailing twelve-month figure through Mar 2026 stood at $568000.0 (down 6.43% YoY), and the FY2025 full-year result was $433000.0, down 23.23% from the prior year.
• Non-Current Deferred Tax Liability for Q1 2026 stood at $568000.0, up from $433000.0 in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $159.3 million in Q4 2022 and bottomed at $351000.0 in Q2 2023.
• The 5-year median for Non-Current Deferred Tax Liability is $786000.0 (2025), against an average of $29.5 million.
• The widest annual swing landed in 2023, when Non-Current Deferred Tax Liability sank 99.7%; it then jumped 268.66% in 2024.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $2.2 million in 2022, then decreased by 8.67% to $2.1 million in 2023, then tumbled by 72.53% to $564000.0 in 2024, then dropped by 23.23% to $433000.0 in 2025, then surged by 31.18% to $568000.0 in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $568000.0 (Q1 2026), $433000.0 (Q4 2025), and $786000.0 (Q3 2025), per Business Quant data.

Peer Comparison